Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2013/05/003684
CTRI/2013/05/003684CompletedPhase 4

COMPARISON OF 2 DAYS VERSUS 5 DAYS OF OCTREOTIDE INFUSION ALONG WITH ENDOSCOPIC THERAPY IN PREVENTING EARLY REBLEED FROM ESOPHAGEAL VARICES â?? A RANDOMIZED CLINICAL STUDY

Jawaharlal Institute of Post graduate Medical Education and Research0 sites120 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
120
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •Patient presenting with upper gastrointestinal bleeding with portal hypertension diagnosed by clinical, biochemical, radiological investigation and presence of esophageal varices confirmed on endoscopy.
  • •-First episode of variceal bleed.
  • •-Age 13 years and above.
  • •-Patient undergoing endoscopic therapy.

Exclusion Criteria

  • •-Concomitant gastric varices or any other additional upper gastrointestinal source of bleed
  • •-Hepatocellular carcinoma / any other malignancy
  • •-Debilitating illness like cerebro vascular accident, severe ischemic heart disease
  • •-Use of vasoactive medicines & endoscopic therapy before being referred to our hospital

Investigators

Sponsor
Jawaharlal Institute of Post graduate Medical Education and Research

Similar Trials

Recruiting
Phase 4
One-day vs five-day of octreotide infusion along with endoscopic therapy in the prevention of early rebleeding and mortality from esophageal varices: randomized control trialCirrhosis with esophageal varices bleedingesophageal varices bleeding
TCTR20221004008Phramongkutklao Hospital236
Unknown
Phase 4
Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled StudyEsophageal Varices
NCT05199038Tanta University184
Not yet recruiting
Not Applicable
To compare 7 days vs 14 days of antibiotics in neonatal bacterial infections.
CTRI/2022/08/044933AIIMS Raipur
Completed
Phase 3
Comparison of quadruple therapy and high dose dual therapy on Helicobacter pylori eradicatioHelicobacter pylori infection.Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhereB96.81
IRCT20131124015510N4Mazandaran University of Medical Sciences240
Completed
Phase 3
Concomitant therapies for first-line Helicobacter pylori eradicatioDuodenal ulcerGastric ulcerCondition 1: Gastric ulcer. Condition 2: Duodenal ulcer.
IRCT20170521034070N2Sari University of Medical Sciences200